Convert this to concise and readable form
Exposure to blood or other potentially infectious body fluid is a medical emergency.
| Step | Timing | Action | Details |
|---|---|---|---|
| 1 | 0 hr / 0 min | Manage exposure site | Wash wound with water + soap; irrigate eye with water/normal saline; rinse mouth with water/saline; refer to physician |
| 2 | ASAP | Establish eligibility for PEP | Assess exposure + source code; exposure within 72 hrs; determine risk of transmission |
| 3 | - | Counsel for PEP | Provide info on HIV/PEP; obtain consent; offer special leave |
| 4 | Ideally within 2 hrs, not more than 72 hrs | Prescribe PEP | Assess source HIV status; check pregnancy (females); explain ARV side effects; explain post-exposure measures for HBV/HCV |
| 5 | - | Laboratory evaluation | HIV pre-test counselling; check Hep B immunization; offer HIV, HBV, HCV tests; CBC + LFT if needed; HIV post-test counselling |
| 6 | 6 months | Follow up & monitor adherence | Record keeping; clinical assessment at 2 weeks; Hep B vaccination if needed; HIV test at 3 and 6 months |
| Type of Exposure | Condition | Exposure Code |
|---|---|---|
| Mucous membrane / compromised skin (volume or duration) | Small volume / few drops / short duration | EC1 |
| Large volume / major splash / long duration | EC2 | |
| Percutaneous (severity) | Less severe | EC2 |
| More severe | EC3 |
| HIV Status | Definition | Source Code |
|---|---|---|
| HIV Negative | Source not HIV+, but consider HBV/HCV | No PEP required |
| HIV Positive | Low viral titre, asymptomatic, high CD4 | HIV SC 1 |
| HIV Positive | High viral titre, advanced disease, low CD4 | HIV SC 2 |
| HIV Status Unknown | Risk in generalized HIV epidemic / key affected population | HIV SC Unknown |
| Exposure Code | Source Code | PEP Recommendation | Duration |
|---|---|---|---|
| 1 | 1 | Not warranted | - |
| 1 | 2 | Recommended | 28 days |
| 2 | 1 | Recommended | 28 days |
| 2 | 2 | Recommended | 28 days |
| 3 | 1 or 2 | Recommended | 28 days |
| 2/3 | Unknown | Consider PEP if HIV prevalence is high in given population | 28 days |
| Regimen | Administration |
|---|---|
| Preferred: TDF (300mg) + 3TC (300mg) + DTG (50mg) FDC | 1 tab within 2 hrs of exposure; next day 1 tab OD - continue for 4 weeks |
| Alternate 1: TDF (300mg) + 3TC (300mg) FDC | 1 tab within 2 hrs; next day 1 tab OD |
| Alternate 2: LPV/r (200/50mg) FDC | 2 tabs within 2 hrs; then 2 tabs BD - continue for 4 weeks |
| Alternate 3: TDF (300mg) + 3TC (300mg) + EFV (600mg) FDC | 1 tab immediately; next day 1 tab OD - continue for 4 weeks |
As per upcoming NACO guidelines (subject to change)